What is it about?

The aim of the study was to determine the influence of maternal sodium valproate (SVP) on neonatal neuroendocrine (hypothalamic-pituitary-adrenal; HPA)-cytokines and oxido-inflammatory axes.

Featured Image

Why is it important?

- Maternal SVP exposure disrupted the maternal/neonatal stress-brain (HPA) axis. - Maternal SVP exposure caused an oxido-inflammatory state in neonates. - Maternal SVP exposure disrupted a neonatal neuroendocrine-cytokines axis. - SVP exposure has a detrimental impact on pups during the perinatal period.

Perspectives

The maternal administration of SVP stimulated the maternal/neonatal stress-brain (HPA) axis. Also, SVP perturbed the production of neonatal adipocytokines triggering the oxidative stress state. A novel interpretation of the results of this study is that the maternal SVP might act as a neonatal oxido-inflammatory and neuroendocrine-cytokines disruptor resulting in multiple adverse actions on neonates during the perinatal period (Figure 3). Based on the results of this study, the HPA axis should be evaluated during and shortly after AEDs (SVP) exposure, as disruption of the responses of the maternal HPA axis can have severe long-term consequences for neonates, particularly the developing brain. Further investigations are required to verify the current data with human health and to determine the precise mechanisms of these disruptions.

Full Professor Ahmed R. G.
Division of Anatomy and Embryology, Zoology department, Faculty of Science, Beni-Suef University, Egypt.

Read the Original

This page is a summary of: Maternal Sodium Valproate Exposure Alters Neuroendocrine-Cytokines and Oxido-inflammatory Axes in Neonatal Albino Rats, Endocrine Metabolic & Immune Disorders - Drug Targets, October 2021, Bentham Science Publishers,
DOI: 10.2174/1871530320999200918120617.
You can read the full text:

Read

Contributors

The following have contributed to this page